Hacksaw Group, the B2B technology platform and game developer, has launched a B2B Prediction Markets platform, pushing into one of the fastest-growing corners of the betting econom
News in Focus


Evoplay, the game studio known for unconventional, out-of-the-box mechanics, has widened its footprint in Spain through a content partnership with Gran Madrid | Casino Online.

Wildz Group says it has become the first iGaming operator granted a license to offer online casino and sports betting products in Finland, a market that opens to private competitio

ICICI Securities has maintained its BUY call on ICICI Lombard General Insurance and raised its target price to Rs 2,000 from Rs 1,932, implying about 17% upside from the current market price of Rs

Anand Rathi Share and Stock Brokers has maintained its BUY rating on LTIMindtree (LTM) and raised its 12-month target price to Rs 5,125 from Rs 4,717, implying about 16.7% upside from the Rs 4,390

Motilal Oswal has reiterated its BUY call on ICICI Bank with a target price of Rs 1,750, about 25% above the current market price of Rs 1,397 after a stellar second quarter.
Main Regional Stories

ICICI Securities has maintained its BUY rating on CEAT with an unchanged target price of Rs 4,500, implying about 40% upside from the current market price of Rs 3,222.

Motilal Oswal Financial Services has reiterated its BUY rating on DLF and raised its target price to Rs 780, implying about 16% upside from the current market price of Rs 674.

ICICI Securities has maintained its BUY rating on Tata Communications with a sum-of-the-parts target price of Rs 2,130, implying about 21% upside from the current market price of Rs 1,764.

BOB Capital Markets has maintained its BUY rating on Karur Vysya Bank and raised its target price to Rs 413 from Rs 362, implying about 19% upside from the Rs 346 close on Oct. 15, 2026.
Mumbai: India’s top software services exporter, Tata Consultancy Services has signed up a $1.2 billion d
Washington - Officials said that 21 schools of Bedford county in souther
Washington: Bristol-Myers Squibb Co.’s made new chemotherapy drug called Ixempra for women with ad








